NCT06687720View on ClinicalTrials.gov

A Clinical Study to Determine the Safety and Efficacy of An Oral Probiotic Supplementation in the Management of Irritable Bowel Syndrome With Protein Digestion.

NANot yet recruitingINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

November 30, 2024

Primary Completion Date

November 30, 2024

Study Completion Date

November 30, 2024

Conditions
Irritable Bowel Syndrome
Interventions
OTHER

MetBroma

Mode of Usage: Take one slow-release capsule twice a day, after meal Dosage Form: Capsule Unit Dose Route of administration: Oral frequency: Twice a day

Sponsors
All Listed Sponsors
collaborator

Meteoric Biopharmaceuticals Pvt. Ltd.

INDUSTRY

lead

NovoBliss Research Pvt Ltd

OTHER

NCT06687720 - A Clinical Study to Determine the Safety and Efficacy of An Oral Probiotic Supplementation in the Management of Irritable Bowel Syndrome With Protein Digestion. | Biotech Hunter | Biotech Hunter